Robert Tansley

Statistics

Publications

Citations

H-Index

Active since

2010

Affiliations

Retina Vitreous Associates Medical Group(Current)

Robert Tansley is an author at Retina Vitreous Associates Medical Group specializing in pharmacotherapy, hypersensitivity, and atopic dermatitis treatment.

Publications per year

2010–2019

Publications

A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single Enantiomer (+)-Mefloquine Compared with Racemic Mefloquine in Healthy Persons

Robert Tansley, Julie Lotharius, Anthony Priestley et al. · American Journal of Tropical Medicine and Hygiene · 2010 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision

Jennifer K. Sun, Raj K. Maturi, David S. Boyer et al. · Ophthalmology Retina · 2019 · 19 citations

Medicine, Ophthalmology, Pharmacotherapy +10

The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle‐controlled study

R Holst, Sakari Reitamo, Rumyana Yankova et al. · Allergy · 2010 · 18 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.

Jo Lynne Herzog, James Solomon, Zoe Diana Draelos et al. · PubMed · 2011 · 18 citations

Pharmacy, Dermatology, Pharmacotherapy +17

1–4 of 4